Early decrease in circulating dendritic cells number after liver transplantation could favor hepatitis C virus recurrence

Journal of Medical Virology

Volumn 78, Issue 8, 2006, Pages 1070-1075

  Schvoerer, Evelyne ^a,d   Thumann, Christine ^a   Spohrer, Stephan ^a   Soulier, Eric ^a   Royer, Cathy ^a   Brignon, Nicolas ^a   Doridot, Stéphane ^a   Meyer, Nicolas ^b   Ellero, Bernard ^c   Woehl Jaegle, Marie Lorraine ^c   Meyer, Carole ^c   Wolf, Philippe ^c   Jaeck, Daniel ^c   Stoll Keller, Françoise ^a  

^a INSERM   (France)

^b HÔPITAL CIVIL   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d Institut de virologie   (France)

Author keywords

Dendritic cells; HCV recurrence; Liver transplantation

Indexed keywords

ALPHA INTERFERON; CD4 ANTIGEN; INTERLEUKIN 12;

ADULT; ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; QUANTITATIVE ANALYSIS; RECURRENCE RISK; REINFECTION;

CELL COUNT; DENDRITIC CELLS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; RECURRENCE; TIME FACTORS;

HEPATITIS C VIRUS;

EID: 33745699000     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20664     Document Type: Article

References (10)

1. Anthony DD, Yonkers NL, Post AB, Asaad R, Heinzel FP, Lederman MM, Lehmann PV, Valdez H. 2004. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol 172:4907-4916.
2. Auffermann-Gretzinger S, Keeffe EB, Levy S. 2001. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97:3171-3176.
3. Kanto T, Inoue M, Miyatake H, Sato A, Sakakibara M, Yakushijin T, Oki C, Itose I, Hiramatsu N, Takehara T, Kasahara A, Hayashi N. 2004. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J Infect Dis 190:1919-1926.
4. Longman RS, Talal AH, Jacobson IM, Albert ML, Rice CM. 2004. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103:1026-1029.
5. Longman RS, Talal AH, Jacobson IM, Rice CM, Albert ML. 2005. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis 192:497-503.
6. Matsue H, Yang C, Matsue K, Edelbaum D, Mummert M, Takashima A. 2002. Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation. J Immunol 169:3555-3564.
7. Mazariegos GV, Zahorchak AF, Reyes J, Ostrowski L, Flynn B, Zeevi A, Thomson AW. 2003. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3:689-696.
8. McCaughan GW, Zekry A. 2004. Mechanisms of HCV reinfection and allograft damage after liver transplantation. J Hepatol 40:368-374.
9. Suda T, Chida K, Matsuda H, Hashizume H, Ide K, Yokomura K, Suzuki K, Kuwata H, Miwa S, Nakano H, Fujisawa T, Enomoto N, Matsushita A, Nakamura H. 2003. High-dose intravenous glucocorticoid therapy abrogates circulating dendritic cells. J Allergy Clin Immunol 112:1237-1239.
10. Womer KL, Peng R, Patton PR, Kaleem A, Bucci M, Murawski MR, Schold J, Efron PA, Hemming AW, Srinivas TR, Meier-Kriesche HU, Kaplan B, Clare-Salzler MJ. 2005. The effects of renal transplantation on circulating precursor dendritic cells. Transplant Proc 37:3-6.